Marcos EG - Search Results

1

Atrial fibrillation progression and outcome in patients with young-onset atrial fibrillation.

De With RR, Marcos EG, Van Gelder IC, Rienstra M. De With RR, et al. Among authors: marcos eg. Europace. 2018 Nov 1;20(11):1750-1757. doi: 10.1093/europace/euy028. Europace. 2018. PMID: 29518195

2

Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study).

Ko D, Riles EM, Marcos EG, Magnani JW, Lubitz SA, Lin H, Long MT, Schnabel RB, McManus DD, Ellinor PT, Ramachandran SV, Wang TJ, Gerszten RE, Benjamin EJ, Yin X, Rienstra M. Ko D, et al. Among authors: marcos eg. Am J Cardiol. 2016 Nov 15;118(10):1493-1496. doi: 10.1016/j.amjcard.2016.08.010. Epub 2016 Aug 24. Am J Cardiol. 2016. PMID: 27666170 Free PMC article.

3

Relation of renal dysfunction with incident atrial fibrillation and cardiovascular morbidity and mortality: The PREVEND study.

Marcos EG, Geelhoed B, Van Der Harst P, Bakker SJL, Gansevoort RT, Hillege HL, Van Gelder IC, Rienstra M. Marcos EG, et al. Europace. 2017 Dec 1;19(12):1930-1936. doi: 10.1093/europace/euw373. Europace. 2017. PMID: 28108549

4

Atrial fibrillation progression risk factors and associated cardiovascular outcome in well-phenotyped patients: data from the AF-RISK study.

De With RR, Marcos EG, Dudink EAMP, Spronk HM, Crijns HJGM, Rienstra M, Van Gelder IC. De With RR, et al. Among authors: marcos eg. Europace. 2020 Mar 1;22(3):352-360. doi: 10.1093/europace/euz339. Europace. 2020. PMID: 31865391

5

Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome.

Marcos EG, De With RR, Mulder BA, Van Gelder IC, Rienstra M. Marcos EG, et al. Int J Cardiol Heart Vasc. 2019 Nov 7;25:100429. doi: 10.1016/j.ijcha.2019.100429. eCollection 2019 Dec. Int J Cardiol Heart Vasc. 2019. PMID: 31890859 Free PMC article.

6

Tailored treatment strategies: a new approach for modern management of atrial fibrillation.

Van Gelder IC, Hobbelt AH, Marcos EG, Schotten U, Cappato R, Lewalter T, Schwieler J, Rienstra M, Boriani G. Van Gelder IC, et al. Among authors: marcos eg. J Intern Med. 2016 May;279(5):457-66. doi: 10.1111/joim.12489. Epub 2016 Mar 16. J Intern Med. 2016. PMID: 26991684 Free article. Review.

7

Tissue velocity imaging of the left atrium predicts response to flecainide in patients with acute atrial fibrillation.

Limantoro I, De Vos CB, Delhaas T, Marcos E, Blaauw Y, Weijs B, Tieleman RG, Pisters R, Schotten U, Van Gelder IC, Crijns HJ. Limantoro I, et al. Heart Rhythm. 2014 Mar;11(3):478-84. doi: 10.1016/j.hrthm.2013.12.010. Epub 2013 Dec 7. Heart Rhythm. 2014. PMID: 24321238

8

Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation.

Marcos EG, Da Fonseca AC, Hofma SH. Marcos EG, et al. Neth Heart J. 2011 Oct;19(10):412-7. doi: 10.1007/s12471-011-0197-y. Neth Heart J. 2011. PMID: 21948020 Free PMC article.

9

Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin.

Santopinto J, Gurfinkel EP, Torres V, Marcos E, Bozovich GE, Mautner B, McCabe CH, Antman EM. Santopinto J, et al. Am Heart J. 2001 Apr;141(4):566-72. doi: 10.1067/mhj.2001.113994. Am Heart J. 2001. PMID: 11275921 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page